Skip to Content
Main Content

The Lymphoma Working Committee provides scientific oversight for studies related to hematopoietic cell transplantation for Hodgkin and non-Hodgkin disease, as well as those studies related to cellular therapy evaluating lymphoma-specific questions or those aiming to compare cellular therapy approaches (e.g. CAR-T vs. autologous transplant).